84 related articles for article (PubMed ID: 7241390)
21. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
Prakash C; Soliman V
Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
[TBL] [Abstract][Full Text] [Related]
22. The effect of pregnancy and treatment with 17 beta-estradiol on the transport of organic anions into isolated rat hepatocytes.
Brock WJ; Vore M
Drug Metab Dispos; 1984; 12(6):713-6. PubMed ID: 6150820
[TBL] [Abstract][Full Text] [Related]
23. Metabolism of MK-499, a class III antiarrhythmic agent, in rats and dogs.
Vickers S; Duncan CA; Slaughter DE; Arison BH; Greber T; Olah TV; Vyas KP
Drug Metab Dispos; 1998 May; 26(5):388-95. PubMed ID: 9571219
[TBL] [Abstract][Full Text] [Related]
24. Hepatic disposition of the acyl glucuronide1-O-gemfibrozil-beta-D-glucuronide: effects of dibromosulfophthalein on membrane transport and aglycone formation.
Sabordo L; Sallustio BC; Evans AM; Nation RL
J Pharmacol Exp Ther; 1999 Feb; 288(2):414-20. PubMed ID: 9918540
[TBL] [Abstract][Full Text] [Related]
25. Choleretic and diuretic properties of dihydroxydibutyl ether in the rat.
Corbic M; Dumont M; De Couët G; Erlinger S
J Pharmacol Exp Ther; 1982 Jun; 221(3):769-74. PubMed ID: 7086686
[TBL] [Abstract][Full Text] [Related]
26. Cholestatic effect of harmol glucuronide in the rat. Prevention of harmol-induced cholestasis by increased formation of harmol sulfate.
Krijgsheld KR; Koster HJ; Scholtens E; Mulder GJ
J Pharmacol Exp Ther; 1982 Jun; 221(3):731-4. PubMed ID: 7086685
[TBL] [Abstract][Full Text] [Related]
27. Biliary secretion of glutathione in estradiol 17beta-D-glucuronide-induced cholestasis.
Mottino AD; Veggi LM; Wood M; Román JM; Vore M
J Pharmacol Exp Ther; 2003 Oct; 307(1):306-13. PubMed ID: 12893835
[TBL] [Abstract][Full Text] [Related]
28. Endogenous steroid metabolism is indicated by fluctuations of endogenous steroid and steroid glucuronide levels in early development of the steelhead trout (Oncorhynchus mykiss).
Yeoh CG; Schreck CB; Feist GW; Fitzpatrick MS
Gen Comp Endocrinol; 1996 Jul; 103(1):107-14. PubMed ID: 8812344
[TBL] [Abstract][Full Text] [Related]
29. Hepatic disposition of the acyl glucuronide 1-O-gemfibrozil-beta-D-glucuronide: effects of clofibric acid, acetaminophen, and acetaminophen glucuronide.
Sabordo L; Sallustio BC; Evans AM; Nation RL
J Pharmacol Exp Ther; 2000 Oct; 295(1):44-50. PubMed ID: 10991959
[TBL] [Abstract][Full Text] [Related]
30. Glucuronidation converts gemfibrozil to a potent, metabolism-dependent inhibitor of CYP2C8: implications for drug-drug interactions.
Ogilvie BW; Zhang D; Li W; Rodrigues AD; Gipson AE; Holsapple J; Toren P; Parkinson A
Drug Metab Dispos; 2006 Jan; 34(1):191-7. PubMed ID: 16299161
[TBL] [Abstract][Full Text] [Related]
31. Bioactivation of a toxic metabolite of valproic acid, (E)-2-propyl-2,4-pentadienoic acid, via glucuronidation. LC/MS/MS characterization of the GSH-glucuronide diconjugates.
Tang W; Abbott FS
Chem Res Toxicol; 1996 Mar; 9(2):517-26. PubMed ID: 8839057
[TBL] [Abstract][Full Text] [Related]
32. Glucuronidation as a transient intermediate metabolic step in the elimination of (-)-carbovir. Identification of (-)-carbovir-5'-O-glucuronide in rat bile.
Zimmerman CL; Iyer KR; Faudskar AL; Remmel RP
Drug Metab Dispos; 1993; 21(5):902-10. PubMed ID: 7902254
[TBL] [Abstract][Full Text] [Related]
33. Interaction of human serum albumin with the electrophilic metabolite 1-O-gemfibrozil-beta-D-glucuronide.
Sallustio BC; Fairchild BA; Pannall PR
Drug Metab Dispos; 1997 Jan; 25(1):55-60. PubMed ID: 9010630
[TBL] [Abstract][Full Text] [Related]
34. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
35. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
36. Structural characterization of anti-HIV drug candidate PA-457 [3-O-(3',3'-dimethylsuccinyl)-betulinic acid] and its acyl glucuronides in rat bile and evaluation of in vitro stability in human and animal liver microsomes and plasma.
Wen Z; Stern ST; Martin DE; Lee KH; Smith PC
Drug Metab Dispos; 2006 Sep; 34(9):1436-42. PubMed ID: 16751262
[TBL] [Abstract][Full Text] [Related]
37. Structure-activity relationship of the cholestatic activity of dihydrotestosterone glucuronide, allo bile acids and lithocholate.
Vore M; Montgomery C; Durham S; Schlarman D; Elliott WH
Life Sci; 1989; 44(26):2033-40. PubMed ID: 2747415
[TBL] [Abstract][Full Text] [Related]
38. Metabolism and excretion of atorvastatin in rats and dogs.
Black AE; Hayes RN; Roth BD; Woo P; Woolf TF
Drug Metab Dispos; 1999 Aug; 27(8):916-23. PubMed ID: 10421619
[TBL] [Abstract][Full Text] [Related]
39. [The enterohepatic circulation of estradiol and ethinylestradiol in the rat].
Löffler S; Bolt HM
Arzneimittelforschung; 1980; 30(5):810-3. PubMed ID: 7190425
[TBL] [Abstract][Full Text] [Related]
40. Disposition and covalent binding of diflunisal and diflunisal acyl glucuronide in the isolated perfused rat liver.
Wang M; Dickinson RG
Drug Metab Dispos; 1998 Feb; 26(2):98-104. PubMed ID: 9456294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
